Our study population had average depression rates of 16.9% preintervention and 15% postintervention; therefore, we hypothesize that this nonsignificant improvement in the post-CRP depression score could have resulted from the COVID-19 pandemic. The gene discussed is CRP; the disease is major depressive disorder.